Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor

Clinical trial NCT02246127 · COMPLETED

Trial details

NCT number: NCT02246127
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2014-10-27
Primary completion: 2020-11-18
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.